| Project/Area Number |
24390136
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Partial Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Medical sociology
|
|---|
| Research Institution | National Cardiovascular Center Research Institute |
|---|
Principal Investigator |
AKAGAWA Eiki 独立行政法人国立循環器病研究センター, 研究開発基盤センター, 室長 (40416219)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
OHYA Tomoko 独立行政法人国立循環器病研究センター, 研究開発基盤センター, 研究員 (30437305)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
HASEGAWA Shuhei 独立行政法人国立循環器病研究センター, 研究開発基盤センター, 室長
NAKADA Haruka 独立行政法人国立循環器病研究センター, 研究開発基盤センター, 特任研究員 (10592248)
IWATA Michiaki 独立行政法人国立循環器病研究センター, 研究開発基盤センター, 研究員
OHYA Tomoko 独立行政法人国立循環器病研究センター, 研究開発基盤センター, 特任研究員 (30437305)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥13,910,000 (Direct Cost: ¥10,700,000、Indirect Cost: ¥3,210,000)
Fiscal Year 2014: ¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
|
|---|
| Keywords | 医療政策 / 産学連携 / イノベーション / 技術移転 / 製品化 |
|---|
| Outline of Final Research Achievements |
In the conventional generic IP evaluation, patentability and business feasibility have been positioned as key indicators. However, in the case of technology transfer (TT) of medical technologies, it should also be considered in medical significance in addition to above two indicators. In order to lead to the commercialization of medical technologies (including medical devices, pharmaceutical and so on), intellectual property (IP) resulting from the study must have been evaluated quantitatively under the consideration of clinical situation. Thereby, there is a possibility to promote TT from academia to industry. To assist in the review and decision making process of IP of medical devices deliberation, we developed a scoring evaluation tool which consisted of three major criteria (1. patentability, 2. business feasibility, and 3. social aspects). While the tool’s utility was recognized, it has also been tended to that there are biases in the part of results of minor criteria.
|
